HQL
Tekla Life Sciences Investors
17.40$
+0.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q3 23 | Q1 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.00 | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | -0.04 | -0.04 | -0.04 | |
| – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | |
| – | 0.00 | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | – | – | – | – | 0.15 | 0.72 | 0.33 | |
| – | – | – | – | – | – | – | – | – | – | 1.10 | 0.60 | |
| – | – | – | – | – | – | – | – | – | -0.29 | -0.80 | -0.55 | |
| – | 0.00 | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | |
| – | 0.00 | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | -0.04 | -0.04 | -0.04 |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.